DARE - Daré Bioscience to Participate in Three November Conferences | Benzinga
SAN DIEGO, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that the company's President and CEO, Sabrina Martucci Johnson, and Medical Advisor Andrew T. Goldstein, MD, will participate in the following conferences in November 2023:
Event: Collaborating for Novel Solutions (CNS) Summit 2023
Format: Session Moderation by Sabrina Martucci Johnson
Session: Women's Health: Tapping Into The People Who Control 80% Of The Healthcare Purchasing Decisions
Date / Time: Friday, November 10, 2023; 12:00 p.m. – 12:50 p.m. EST
Location: Boston, MA
Details: The session will explore the high-return opportunities to advance women's health R&D through collaboration, and how doing so is the key to accessing and offering healthcare solutions to the people who control 80% of the healthcare purchasing decisions. The speakers will be:
- Imran Nasrullah, MS, JD, Vice President & Head, Collaborate to Cure Hub US, Business Development & Licensing, Bayer Pharmaceuticals
- Andrew Khair, Director, Strategy, Business Development, New Product Planning, Ferring Pharmaceuticals
Event: Stifel 2023 Healthcare Conference
Format: Company Presentation by Sabrina Martucci Johnson
Date / Time: Tuesday, November 14, 2023; 4:45 p.m. EST
Location: New York, NY
Details: A live webcast of Ms. Johnson's presentation will be available at https://wsw.com/webcast/stifel83/dare/2064568 and under "Presentations, Events & Webcasts" in the Investors section of the company's website at https://ir.darebioscience.com. The webcast will be archived in the same section of ...